Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
10/2004
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs
10/07/2004US20040198781 Carbonic anhydrase inhibitor
10/07/2004US20040198779 Antiinflammatory agents; adult respiratory distress syndrome
10/06/2004EP1169312B1 Glucokinase activators
10/05/2004US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents
10/05/2004CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
09/2004
09/30/2004WO2004083193A1 Amide compound and bactericide composition containing the same
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents
09/30/2004US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide
09/30/2004US20040192653 P38 inhibitors and methods of use thereof
09/29/2004EP1129082B1 Method and novel intermediate products for producing isoxazolin-3-yl-acylbenzenes
09/29/2004EP0736016B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
09/29/2004CN1533382A 哌嗪衍生物 Piperazine derivatives
09/29/2004CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
09/29/2004CN1168713C Synthetic reoutes for the preparation of rhionvirus protease inhibitor and key intermediates
09/29/2004CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors
09/28/2004US6797723 Heterocycle substituted diphenyl leukotriene antagonists
09/28/2004CA2114696C 4-benzoylisoxazole herbicides
09/23/2004WO2004080925A2 Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes
09/23/2004WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use
09/23/2004WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004WO2003072552A8 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
09/23/2004US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/23/2004US20040186088 Mercapto-cycloalkyl or heterocyclyl ring-sulfonyl-aryl or heteroaryl derivatives; preventing the cleavage Of tumor necrosis factor- alpha from cell membranes in mammal; treating autoimmune diseases, inflammation, inflammatory bowel disease, Crohn's disease, asthma, sepsis and septic shock
09/22/2004EP1458694A2 Therapeutic compounds for treating dyslipidemic conditions
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
09/22/2004CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof
09/21/2004US6794392 Cell differentiation inducer
09/21/2004US6794372 Nitrate salts of antimicrobial agents
09/21/2004CA2114017C Amide tetrazole acat inhibitors
09/16/2004WO2004078116A2 P38 inhibitors and methods of use thereof
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180896 P38 inhibitors and methods of use thereof
09/16/2004US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004075864A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections
09/09/2004US20040176253 Herbicides; broad active spectrum; on soil and above ground plant parts use
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1165522C Bradykinin receptor antagonists
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171829 Convergent synthesis of alpha-aryl-beta-ketonitriles
09/02/2004US20040171618 Compounds as PDE IV and TNF-inhibitors
09/02/2004US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/01/2004EP1451163A1 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
09/01/2004EP1451162A1 Substituted diphenyl heterocycles useful for treating hcv infection
09/01/2004CN1525959A Muller Klaus-helmut
09/01/2004CN1524960A Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
08/2004
08/31/2004US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts
08/31/2004US6784287 Organic dye molecules and nonlinear optical polymeric compounds containing chromophores
08/31/2004US6784199 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
08/26/2004WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors
08/26/2004WO2004072052A2 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus
08/26/2004WO2004072051A1 Isoxazole compounds as inhibitors of heat shock proteins
08/26/2004WO2004072050A1 Heterocyclic compounds useful as nurr-1 activators
08/26/2004WO2004071442A2 Novel bicyclic compounds and compositions
08/26/2004WO2004047744A3 3-heterocyclic benzylamide derivatives as potassium channel openers
08/26/2004WO2004045392A3 Diagnostic method for celiac sprue
08/26/2004US20040167188 Protein-tyrosine phosphatase inhibitors and uses thereof
08/26/2004US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167069 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity
08/26/2004CA2515847A1 Heterocyclic compounds useful as nurr-1 activators
08/26/2004CA2515638A1 Novel bicyclic compounds and compositions
08/25/2004EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
08/25/2004EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors
08/25/2004EP1448193A1 Therapeutic compounds for treating dyslipidemic conditions
08/25/2004EP1149069B1 Phenylglycine derivatives
08/25/2004EP1131307B1 Method of producing 2-alkyl-3-(4,5-dihydroisoxazole-3-yl)-halobenzenes
08/25/2004CN1524075A Substitued arylketones
08/25/2004CN1163464C Process for preparing intermediate
08/24/2004US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2
08/19/2004WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004WO2004002409A3 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/19/2004US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease
08/19/2004CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/18/2004EP1294366B1 Pharmaceutical compounds for treating copd
08/18/2004EP1284969B1 3-(4,5-dihydroisoxazole-5-yl)benzoylcyclohexenones and the use thereof as herbicides
08/18/2004EP1212309B1 Caspase inhibitor
08/18/2004CN1522250A Cyclic diamine compound having five-membered cyclic group
08/12/2004WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
08/12/2004US20040157900 Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
08/12/2004US20040157881 Function regulator for retinoid relative receptor
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 115